acetazolamide

Generic: acetazolamide

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name acetazolamide
Generic Name acetazolamide
Labeler a-s medication solutions
Dosage Form TABLET
Routes
ORAL
Active Ingredients

acetazolamide 125 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-5617
Product ID 50090-5617_1e171f8d-bb71-4123-b98a-4d33aacd9f03
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA205530
Listing Expiration 2026-12-31
Marketing Start 2016-10-27

Pharmacologic Class

Established (EPC)
carbonic anhydrase inhibitor [epc]
Mechanism of Action
carbonic anhydrase inhibitors [moa]
Chemical Structure
sulfonamides [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500905617
Hyphenated Format 50090-5617

Supplemental Identifiers

RxCUI
197303
UNII
O3FX965V0I
NUI
N0000175517 N0000000235 M0020790

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name acetazolamide (source: ndc)
Generic Name acetazolamide (source: ndc)
Application Number ANDA205530 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 125 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (50090-5617-0)
  • 12 TABLET in 1 BOTTLE (50090-5617-1)
source: ndc

Packages (2)

Ingredients (1)

acetazolamide (125 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "1e171f8d-bb71-4123-b98a-4d33aacd9f03", "openfda": {"nui": ["N0000175517", "N0000000235", "M0020790"], "unii": ["O3FX965V0I"], "rxcui": ["197303"], "spl_set_id": ["07fd0bde-8f7c-47d2-9e81-2c1eee259fa6"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_epc": ["Carbonic Anhydrase Inhibitor [EPC]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (50090-5617-0)", "package_ndc": "50090-5617-0", "marketing_start_date": "20210823"}, {"sample": false, "description": "12 TABLET in 1 BOTTLE (50090-5617-1)", "package_ndc": "50090-5617-1", "marketing_start_date": "20210823"}], "brand_name": "acetazolamide", "product_id": "50090-5617_1e171f8d-bb71-4123-b98a-4d33aacd9f03", "dosage_form": "TABLET", "pharm_class": ["Carbonic Anhydrase Inhibitor [EPC]", "Carbonic Anhydrase Inhibitors [MoA]", "Sulfonamides [CS]"], "product_ndc": "50090-5617", "generic_name": "acetazolamide", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "acetazolamide", "active_ingredients": [{"name": "ACETAZOLAMIDE", "strength": "125 mg/1"}], "application_number": "ANDA205530", "marketing_category": "ANDA", "marketing_start_date": "20161027", "listing_expiration_date": "20261231"}